Androgen deprivation therapy (ADT) use in Medicare beneficiaries with nonmetastatic (M0) prostate cancer (PC) in the United States.
Year: 2012
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Thomas J. Arneson, Karynsa Cetin, Scott Stryker, Alexander Liede, Tom Murray, Shuling Li, Anne Hudson Blaes
Institutions: Amgen (United States), University of Minnesota
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2596590076
